← Open Payments lookup

ERIC YENCHI: Open Payments

NPI 1346723970 · CLINTON, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,146 in 60 payments from 10 companies in 2025. Trend: 2023 $851 · 2024 $1,339 · 2025 $2,146

Food & beverage: $1,186Consulting: $960
CompanyPaymentsAmount
E.R. Squibb & Sons, L.L.C.15$1,184
Vanda Pharmaceuticals Inc.8$247
ABBVIE INC.10$171
Lundbeck LLC7$158
Otsuka America Pharmaceutical, Inc.11$157
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$110
Neurocrine BioSciences, Inc.2$44
Janssen Pharmaceuticals, Inc1$30
Gilead Sciences, Inc.1$30
Alkermes, Inc.1$15

Products named: COBENFY, REXULTI, VRAYLAR, FANAPT, ABILIFY ASIMTUFII, CAPLYTA, HETLIOZ, INGREZZA.

Industry payments across MD — which companies pay providers there.